Cindy Tahl - 25 Jan 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
General Counsel and Secretary
Signature
/s/ Cindy Tahl
Issuer symbol
FATE
Transactions as of
25 Jan 2022
Net transactions value
$0
Form type
4
Filing time
27 Jan 2022, 15:06:06 UTC
Previous filing
13 Jan 2022
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Award $0 +33,302 +21% $0.000000 189,151 25 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Award $0 +53,058 $0.000000 53,058 25 Jan 2022 Common Stock 53,058 $39.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2023, January 8, 2024, January 8, 2025 and January 8, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date.
F2 The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date.

Remarks:

General Counsel and Secretary